Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile
Monofunctional platinum(II) complexes of general formula cis-[Pt(NH3)2(N-heterocycle)Cl]Cl bind DNA at a single site, inducing little distortion in the double helix. Despite this behavior, these compounds display significant antitumor properties, with a different spectrum of activity than that of cl...
Main Authors: | Park, Ga Young, Wilson, Justin Jeff, Song, Ying, Lippard, Stephen J. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemistry |
Format: | Article |
Language: | en_US |
Published: |
National Academy of Sciences (U.S.)
2013
|
Online Access: | http://hdl.handle.net/1721.1/76786 https://orcid.org/0000-0002-2693-4982 |
Similar Items
-
Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin
by: Riddell, Imogen Anne, et al.
Published: (2016) -
Understanding and Improving Platinum Anticancer Drugs - Phenanthriplatin
by: Johnstone, Timothy, et al.
Published: (2015) -
Interaction of the New Monofunctional Anticancer Agent Phenanthriplatin With Transporters for Organic Cations
by: Hucke, Anna, et al.
Published: (2018) -
Interaction of the New Monofunctional Anticancer Agent Phenanthriplatin With Transporters for Organic Cations
by: Anna Hucke, et al.
Published: (2018-05-01) -
Comparison of phenanthriplatin, a novel monofunctional platinum based anticancer drug candidate, with cisplatin, a classic bifunctional anticancer drug
by: Li, Meiyi, S.M. Massachusetts Institute of Technology
Published: (2013)